منابع مشابه
Commentary: Does screening reduce preterm births?
Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295-8. 9 Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, et al. The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol 1995;173:1231-5. 10 Brocklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in preg...
متن کاملDoes antenatal Betamethasone improve neonatal outcome in late preterm births?
Background and Objective: Preterm birth is a public health problem and late preterm birth (deliveries between 34-36 weeks of gestation) accounts for 75% of all preterm births. Antenatal Betamethasone can reduce the severity of respiratory distress in preterm infants and its effect is accepted in 24-34 weeks of gestation. Our goal was to determine the neonatal outcomes of Betamethasone prescr...
متن کاملDoes antenatal Betamethasone improve neonatal outcome in late preterm births?
Introduction: Preterm birth is a public health problem and late preterm birth (deliveries between 34-36 weeks of gestation) accounts for 75% of all preterm births. Antenatal Betamethasone can reduce the severity of respiratory distress in preterm infants and its effect is accepted in 24-34 weeks of gestation. Our goal was to determine the neonatal outcomes of Betamethasone prescription in late ...
متن کاملdoes antenatal betamethasone improve neonatal outcome in late preterm births?
background and objective: preterm birth is a public health problem and late preterm birth (deliveries between 34-36 weeks of gestation) accounts for 75% of all preterm births. antenatal betamethasone can reduce the severity of respiratory distress in preterm infants and its effect is accepted in 24-34 weeks of gestation. our goal was to determine the neonatal outcomes of betamethasone prescript...
متن کاملDoes PSA screening reduce prostate cancer mortality?
question whether the recent decline in age-standardized prostate cancer mortality rates in Quebec could be attributed to screening with the serum prostate-specific antigen (PSA) test. By comparing the change in the incidence rate of prostate cancer between 1989 and 1993 with the change in the prostate cancer mortality rate between 1995 and 1999 in 15 birth cohorts, and in 15 regions of Quebec, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2004
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.329.7462.374